Anixa Biosciences, Inc. (ANIX)

Anixa Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 10, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020
Market Cap	143	113	98	173	143	50
Market Cap Growth	40.56%	14.50%	-43.15%	20.77%	186.96%	-36.52%
Enterprise Value	126.71	91.86	73.73	142.76	107.16	40.4
Last Close Price	4.33	3.50	3.16	5.60	4.77	2.06
PE Ratio	-	-8.97	-9.87	-12.44	-10.60	-4.58
PS Ratio	-	-	468.66	-	279.97	-
PB Ratio	8.56	5.64	4.04	5.96	4.04	5.70
P/TBV Ratio	8.42	5.58	4.02	5.86	3.85	5.23
P/FCF Ratio	-	-15.36	-15.85	-26.67	-29.03	-8.07
P/OCF Ratio	-	-15.36	-15.85	-26.67	-29.03	-8.09
EV/Sales Ratio	-	-	351.10	-	209.31	-
EV/EBITDA Ratio	-	-6.66	-6.72	-10.32	-8.20	-4.09
EV/EBIT Ratio	-	-6.64	-6.70	-10.29	-8.16	-4.05
EV/FCF Ratio	-	-12.52	-11.88	-21.99	-21.70	-6.52
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0
Debt / EBITDA Ratio	-0.02	-0.02	-0.02	-0.02	-0.02	-0.01
Debt / FCF Ratio	-0.03	-0.03	-0.03	-0.03	-0.05	-0.01
Asset Turnover	0	0	0.01	0	0.02	0
Quick Ratio	7.76	8.04	11.89	14.60	28.13	7.62
Current Ratio	8.45	8.54	12.50	14.83	28.35	7.88
Return on Equity (ROE)	-65.42%	-60.10%	-38.51%	-43.74%	-61.02%	-154.36%
Return on Assets (ROA)	-61.10%	-58.71%	-39.37%	-41.62%	-57.48%	-126.73%
Return on Capital (ROIC)	-4804.81%	-5811.34%	-4626.47%	-5036.30%	-6073.92%	-5867.68%
Return on Capital Employed (ROCE)	-69.14%	-64.96%	-42.46%	-43.80%	-60.74%	-152.61%
Earnings Yield	-7.80%	-11.14%	-10.13%	-8.04%	-9.43%	-21.84%
FCF Yield	-4.80%	-6.51%	-6.31%	-3.75%	-3.44%	-12.39%
Buyback Yield / Dilution	-1.89%	-3.03%	-0.37%	-0.26%	-22.03%	-18.83%
Total Shareholder Return	-	-3.03%	-0.37%	-0.26%	-22.03%	-18.83%

Updated Sep 10, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q